Viking Therapeutics Statistics

Total Valuation

VKTX has a market cap or net worth of $4.42 billion. The enterprise value is $3.81 billion.

Market Cap	4.42B
Enterprise Value	3.81B

Important Dates

The next estimated earnings date is Wednesday, July 22, 2026, after market close.

Earnings Date	Jul 22, 2026
Ex-Dividend Date	n/a

Share Statistics

VKTX has 116.11 million shares outstanding. The number of shares has increased by 2.12% in one year.

Current Share Class	116.11M
Shares Outstanding	116.11M
Shares Change (YoY)	+2.12%
Shares Change (QoQ)	+1.37%
Owned by Insiders (%)	2.39%
Owned by Institutions (%)	63.59%
Float	113.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	8.78
P/TBV Ratio	8.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.72

Current Ratio	5.72
Quick Ratio	5.67
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-15,687.44

Financial Efficiency

Return on equity (ROE) is -70.04% and return on invested capital (ROIC) is -46.49%.

Return on Equity (ROE)	-70.04%
Return on Assets (ROA)	-42.54%
Return on Invested Capital (ROIC)	-46.49%
Return on Capital Employed (ROCE)	-100.02%
Weighted Average Cost of Capital (WACC)	7.98%
Revenue Per Employee	n/a
Profits Per Employee	-$8.01M
Employee Count	59
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +40.42% in the last 52 weeks. The beta is 0.68, so VKTX's price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	+40.42%
50-Day Moving Average	31.60
200-Day Moving Average	32.66
Relative Strength Index (RSI)	72.57
Average Volume (20 Days)	2,692,257

Short Selling Information

The latest short interest is 22.37 million, so 19.27% of the outstanding shares have been sold short.

Short Interest	22.37M
Short Previous Month	22.28M
Short % of Shares Out	19.27%
Short % of Float	19.75%
Short Ratio (days to cover)	10.03

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-502.00M
Pretax Income	-472.34M
Net Income	-472.34M
EBITDA	n/a
EBIT	-502.00M
Earnings Per Share (EPS)	-$4.16

Full Income Statement

Balance Sheet

The company has $602.96 million in cash and n/a in debt, giving a net cash position of $602.96 million or $5.19 per share.

Cash & Cash Equivalents	602.96M
Total Debt	n/a
Net Cash	602.96M
Net Cash Per Share	$5.19
Equity (Book Value)	501.92M
Book Value Per Share	4.33
Working Capital	501.88M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-340.33M
Capital Expenditures	n/a
Depreciation & Amortization	405,000
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VKTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.12%
Shareholder Yield	-2.12%
Earnings Yield	-10.69%
FCF Yield	n/a

Analyst Forecast

The average price target for VKTX is $92.58, which is 143.38% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$92.58
Price Target Difference	143.38%
Analyst Consensus	Strong Buy
Analyst Count	20
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1